Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 31,649

Document Document Title
WO/2018/007764A1
The invention relates to a method for converting levoglucosenone into 4-hydroxymethyl butyrolactone and 4-hydroxymethyl butenolide without using any solvent or catalyst, wherein the oxidation and hydrolysis of the levoglucosenone or hydr...  
WO/2018/008737A1
The present invention addresses the problem of providing a compound which exerts its effect on the onset mechanism of Parkinson's disease by inhibiting the degeneration and cell death of dopamine-secreting cells, and a therapeutic or pro...  
WO/2018/008442A1
The purpose of the present invention is to provide: a π-conjugated compound exhibiting excellent light emission characteristics; an organic electroluminescent element using same; a display device; and an illumination device. Accordingly...  
WO/2018/007198A1
The present invention relates to the preparation of Thapsigargin (1) and Nortrilobolide (2). The invention further relates to intermediates and preparation of said intermediates which are useful for the preparation of (1) and (2).  
WO/2018/003968A1
The purpose of the present invention is to provide an industrial production method by which an ethylenically unsaturated group-containing γ-butyrolactone derivative is highly selectively obtained with use of a low-cost catalyst that is ...  
WO/2018/002291A1
The invention relates to a process for preparing 2,5-furandicarboxylic acid (FDCA) from furfuryl alcohol comprising: i) preparing 2,5-bis(hydroxymethyl)furan (BHMF) by hydroxymethylation of furfuryl alcohol by formaldehyde in aqueous sol...  
WO/2018/004095A1
The present invention relates to a compound, for an organic optoelectronic device, expressed by chemical formula (1), a composition for an organic optoelectronic device, an organic optoelectronic device having applied same, and a display...  
WO/2018/004315A2
The present specification relates to a compound of chemical formula 1 and an organic electronic element comprising the same.  
WO/2018/003945A1
[Problem] Provided are a method for producing 2-propanil 4-{(3S,5aR,6R,7R,8aS)-6-[(1E,3R)-4-(2,5-difluorophenoxy)-3-h ydroxy-1-butene-1-yl]-7-hydroxyoctahydro-2H-cyclopenta[b]oxe pine-3-yl}butanoate, which can solve various problems desc...  
WO/2018/003295A1
The present invention addresses the problem of providing: a 5-hydroxymethyl-2-furfural (5-HMF) production method which is suitable for the production of 5-hydroxymethyl-2-furfural (5-HMF) on an industrial scale; and a novel catalyst comp...  
WO/2018/004096A1
The present invention relates to a compound, for an organic optoelectronic device, expressed by chemical formula (1), a composition for an organic optoelectronic device, an organic optoelectronic device having applied same, and a display...  
WO/2018/004461A1
Disclosed herein is a catalyst composition that contains M0O3 supported on a carbonaceous material substrate, wherein MoO3 is present in an amount of from 2.0 wt% to 20.0 wt% of the composition and carbon is present in an amount of from ...  
WO/2017/222532A1
A process for the preparation of diastereomeric mono- and 2,5- bis(halomethyl)tetrahydrofurans from renewable THF-diols is described. Also disclosed are certain derivative compounds that can be prepared from the mono or di-alkyl halide f...  
WO/2017/220041A2
Disclosed are a bezafibrate pharmaceutical composition and an application thereof in rheumatoid arthritis. The bezafibrate pharmaceutical composition contains bezafibrate and a natural product compound (I) separated from dried clove buds...  
WO/2017/223151A1
The present disclosure provides a composition containing a sulfonamide aliphatic anhydride grafted olefin-based polymer. The present disclosure also provides a multilayer structure. In an embodiment, a multilayer film is provided and inc...  
WO/2017/223164A1
The present disclosure provides a process for producing an aliphatic sulfonyl azide anhydride and the resultant aliphatic sulfonyl azide anhydride composition. The process includes: (i) thio-acetoxylating an alkenyl carboxylic acid anhyd...  
WO/2017/222953A1
Disclosed are compounds that modulate the physiological action of the proprotein convertase subtilisin kexin type 9 (PCSK9), as well as therapeutic methods for use of such compounds to reduce LDL-cholesterol levels and/or for the treatme...  
WO/2017/220042A2
Disclosed are an amrinone pharmaceutical composition and an application thereof in hypertension treatment. The amrinone pharmaceutical composition contains amrinone and a natural product compound (I) separated from dried blackberry lily ...  
WO/2017/215676A1
A carbidopa pharmaceutical composition and medical use thereof for treating liver cancer are provided. The carbidopa pharmaceutical composition provided in the present invention comprises carbidopa and a naturally produced compound (I) h...  
WO/2017/217676A1
The present invention relates to a novel compound having excellent thermal stability and luminescent ability, and an organic electroluminescent element having enhanced characteristics such as luminous efficiency, driving voltage, and lif...  
WO/2017/217792A1
The present invention relates to an improved method for producing a diphenylmethane derivative which is effective as a sodium-dependent glucose cotransporter (SGLT) inhibitor, the method being carried out by means of a convergent synthes...  
WO/2017/215549A1
Disclosed are an organic electroluminescent compound and an application thereof. The structural formula of the compound is as shown in general formula (1). The material has good fluorescence quantum efficiency and electroluminescence eff...  
WO/2017/217741A1
The present invention relates to a novel brominated furanone derivative, a method for preparing the same, and a pharmaceutical composition containing the same as an active ingredient, wherein the novel brominated furanone derivative or a...  
WO/2017/214493A1
A synthetic fuel is provided. The synthetic fuel includes a base fuel having a first energy density and a compound, the compound including a water absorbing agent for absorbing water from the base fuel to prevent poor combustion and an e...  
WO/2017/214334A1
Disclosed herein are lignin-derived ionic liquids and methods for preparing them. The methods include forming a reaction mixture comprising a lignin-derived starting material, a carbonyl compound, and an amine; maintaining the reaction m...  
WO/2017/209294A1
According to the present invention, it is possible to safely and easily obtain sulfonimidized aromatic compounds using various substrates and a novel sulfonimidization agent by irradiating, with light in the presence of an oxidizer, a co...  
WO/2017/208965A1
The present invention provides an organic compound characterized by being represented by general formula [1] set forth in the claims. In general formula [1], Ar1 and Ar2 are each independently selected from among aryl groups having 6-18 ...  
WO/2017/210072A1
There is provided a compound having Formula (I): (I). In the formula: NpHet is a naphthalene core having at least one fused 5-membered heteroaromatic ring, where the heteroaromatic ring has one heteroatom which is O, S, Se, or Te; Ar1-Ar...  
WO/2017/210525A1
The disclosure relates to a process for the production of a furan derivative from C5 and/or C6 sugars. The process utilizes a water-immiscible organic solvent system comprising at least one alkyl phenol and at least one alkylated naphtha...  
WO/2017/207596A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices, which comprise these compounds.  
WO/2017/209705A3
The present invention relates to a copper aluminium oxide catalyst for preparing a furfuryl alcohol from a furfural, comprising a copper-alumina spinel structure and having surface area in the range from 0.5 to 5 m2 /g; wherein said cata...  
WO/2017/209322A1
The present invention relates to a five-membered heterocyclic compound having an analgesic effect and a pharmaceutical composition comprising a derivative of the five-membered heterocyclic compound. More specifically, the present inventi...  
WO/2017/207555A1
The present invention refers to a process for preparing mesoporous carbon loaded with a catalytically active metal and/or metal oxide nanoparticles, the so-obtained mesoporous carbon and the use thereof as a catalyst in a transfer hydrog...  
WO/2017/207679A1
The invention relates to a method of treatment of aqueous effluent stream obtained during pro- duction of furfural. The aqueous effluent stream containing organic solvents, furfural and water is subjected to azeotropic distillation to ob...  
WO/2017/204556A1
Provided are an organic electronic element and an electronic device therefor, the organic electronic element having a mixture of a compound according to the present invention used as material for an organic layer thereof, thereby enablin...  
WO/2017/203498A1
The present invention relates to methods for extracting cynaropicrin, a sesquiterpene lactone, from leaves of Cynara cardunculus. According to the proposed solution, before cynaropicrin is extracted from the leaves of the Cynara carduncu...  
WO/2017/204634A1
Processes and reactor systems for biomass conversion are described. A continuous process for the conversion of carbohydrate-containing feed material into furanic compounds comprises a reaction step comprising subjecting said feed materia...  
WO/2017/204144A1
Provided is a method for amidating a hydroxy ester compound at a high chemical selectivity. The amidation reaction method for a hydroxy ester compound comprises, in the presence of a catalyst containing a compound of a transition metal o...  
WO/2017/204557A1
Provided are an organic electronic element and an electronic device therefor, the organic electronic element having a mixture of a compound according to the present invention used as a material therefor, thereby enabling the achievement ...  
WO/2017/205795A1
The invention relates to compounds that promote hematopoietic regeneration. The invention further relates to methods of promoting hematopoietic regeneration using the novel compounds of the invention.  
WO/2017/197739A1
Disclosed is an organic electroluminescent material, the molecular general formula thereof being Da-π-Ac, wherein Da is an aggregation-induced luminescent group, π is a conjugated bond and Ac is a strong electron-withdrawing group. The...  
WO/2017/198339A1
The present invention relates to tetrahydropyran derivatives of formula (I) having dual pharmacological activity towards both the sigma (ο) receptor, and the μ-opioid receptor, to processes of preparation of such compounds, to pharmace...  
WO/2017/197670A1
Disclosed in the present application is a method for synthesizing a 1,2-dimethylene cyclobutane chiral compound. The 1,2-dimethylene cyclobutane chiral compound is synthesized from an allenylamine compound in the presence of a rhodium co...  
WO/2017/201233A1
The present disclosure includes methods and systems for removing one or more fermentation inhibitors (e.g., furfural) from a hydrolysate composition (e.g., a whole broth hydrolysate) by gas stripping the one or more fermentation inhibito...  
WO/2017/196081A1
This invention provides a compound for an organic electroluminescent device and an organic electroluminescent device including the same. This invention provides a compound for an organic EL device, which may have high thermal stability, ...  
WO/2017/194662A1
The present invention relates to a selective reduction of specific aldehydes and ketones to their corresponding alcohols.  
WO/2017/193662A1
Crystal forms I and II of tasimelteon. Crystal form I: an X-ray powder diffraction spectrum using CuKα radiation and represented by a 2θ angle has diffraction peaks at least at 7.2º±0.2º, 7.9º±0.2º, 10.6º±0.2º, 14.4º±0.2º, ...  
WO/2017/192498A1
Implementations of the disclosed subject matter provide a process for converting biomass into furfural. The process may include subjecting a pentosan-containing biomass material to an acid catalyzed digestion process in a digestion vesse...  
WO/2017/193041A1
Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.  
WO/2017/191896A1
The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. By using the organic electroluminescent compound of the present disclosure, an organic electroluminesc...  

Matches 1 - 50 out of 31,649